Inventor · disambiguated record
James J. Cunningham
Also filed as: CUNNINGHAM JAMES · CUNNINGHAM JAMES J · CUNNINGHAM JAMES JOHN
13 granted patents·8 pending applications·373 citations·filing 1999–2023
94Inventor score
Top patents by PatentIndex Score
21 records- 0194US9970005B2RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA)SIRNA THERAPEUTICS INC·Filed 2015·Granted May 15, 2018·15 cites·41 claims
- 0294US6916800B2Combination therapy including a matrix metalloproteinase inhibitor and an antineoplastic agentPFIZER·Filed 2004·Granted Jul 12, 2005·53 cites·14 claims
- 0393US11932854B2RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA)SIRNA THERAPEUTICS INC·Filed 2021·Granted Mar 19, 2024·2 cites·25 claims
- 0493US8835623B2RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2013·Granted Sep 16, 2014·15 cites·20 claims
- 0592US9260471B2RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA)CANCILLA MARK·Filed 2011·Granted Feb 16, 2016·60 cites·53 claims
- 0691US11193126B2RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA)SIRNA THERAPEUTICS INC·Filed 2018·Granted Dec 7, 2021·7 cites·40 claims
- 0791US8518907B2RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA)BROWN DUNCAN·Filed 2011·Granted Aug 27, 2013·16 cites·17 claims
- 0891US6858598B1Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasiaSEARLE & CO·Filed 1999·Granted Feb 22, 2005·97 cites·24 claims
- 0989US9850491B2RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2016·Granted Dec 26, 2017·5 cites·15 claims
- 1088US2024247271A1Rna interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (ctnnb1) gene expression using short interfering nucleic acid (sina)SIRNA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1187US9447420B2RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (SINA)SIRNA THERAPEUTICS INC·Filed 2014·Granted Sep 20, 2016·6 cites·39 claims
- 1286US6833373B1Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasiaSEARLE & CO·Filed 1999·Granted Dec 21, 2004·64 cites·3 claims
- 1377US2023030119A1Rna interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (ctnnb1) gene expression using short interfering nucleic acid (sina)SIRNA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1472US6689787B1Method of using an integrin antagonist and radiation therapy as combination therapy in the treatment of neoplasiaSEARLE & CO·Filed 1999·Granted Feb 10, 2004·33 cites·15 claims
- 1568US2019330639A1Rna interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (ctnnb1) gene expression using short interfering nucleic acid (sina)SIRNA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1666US10246714B2RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2017·Granted Apr 2, 2019·0 cites·23 claims
- 1765US2024226251A1Combination therapy using clostridial toxin derivative and at least one chemical depolarizing agentALLERGAN INC·Filed 2022·Application pending·0 cites
- 1861US2004234624A1Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasiaFiled 2004·Application pending·0 cites
- 1955US2005037090A1Combination therapy including a cyclooxygenase-2 inhibitor and an antineoplastic agentFiled 2004·Application pending·0 cites
- 2051US2022096609A1Combination therapy using clostridial toxin derivative and at least one chemical depolarizing agentALLERGAN INC·Filed 2020·Application pending·0 cites
- 2144US2002103141A1Antiangiogenic combination therapy for the treatment of cancerFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when James J. Cunningham files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →